Publications
2023
Abstract 3111: The Sygnature CHARMD platform - combinatorial high-throughput assembly and review of molecular degraders
Hjerpe, R., Birch, L., Brien, A., Cusin, L., Duffy, L., Gourdet, B., . . . Jordan, A. (2023). Abstract 3111: The Sygnature CHARMD platform - combinatorial high-throughput assembly and review of molecular degraders. Cancer Research, 83(7_Supplement), 3111. doi:10.1158/1538-7445.am2023-3111
Cysteine-Selective Modification of Peptides and Proteins via Desulfurative C-C Bond Formation.
Griffiths, R. C., Smith, F. R., Li, D., Wyatt, J., Rogers, D. M., Long, J. E., . . . Mitchell, N. J. (2023). Cysteine-Selective Modification of Peptides and Proteins via Desulfurative C-C Bond Formation.. Chemistry (Weinheim an der Bergstrasse, Germany), 29(16), e202202503. doi:10.1002/chem.202202503
2022
HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
Astbury, S., Reynolds, C. J., Butler, D. K., Muñoz‐Sandoval, D. C., Lin, K., Pieper, F. P., . . . Vijay, A. (n.d.). HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19. Immunology. doi:10.1111/imm.13450
2021
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Urbanowicz, R. A., Tsoleridis, T., Jackson, H. J., Cusin, L., Duncan, J. D., Chappell, J. G., . . . Ollivere, B. J. (2021). Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection. SCIENCE TRANSLATIONAL MEDICINE, 13(609). doi:10.1126/scitranslmed.abj0847
Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
Valdes, A. M., Moon, J. C., Vijay, A., Chaturvedi, N., Norrish, A., Ikram, A., . . . Manisty, C. (2021). Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.. EClinicalMedicine, 34, 100835. doi:10.1016/j.eclinm.2021.100835